Gold Member Since 2016
Audited Supplier
Shenzhen Unique-Peptide Biotechnology Co., Ltd.

Peptides, Cjc-1295, Mod-Grf (1-29) manufacturer / supplier in China, offering Factory Supply--Cjc-1295 No Dac (MOD GRF 1-29) --Ship From USA/France, Peptide Aod9604/Fragment 176-191--Warehouse in USA, France and Australia, Cosmetics Peptide Palmitoyl Oligopeptide (PAL-GHK / palmitoyl-GHK) CAS 147732-56-7 and so on.

(/ )

Supplier Homepage Product GMP peptides Factory Supply--Cjc-1295 No Dac (MOD GRF 1-29) --Ship From USA/France

Factory Supply--Cjc-1295 No Dac (MOD GRF 1-29) --Ship From USA/France

FOB Price: US $4-8 / vial
Min. Order: 10 vial
Min. Order FOB Price
10 vial US $4-8/ vial
Get Latest Price
Production Capacity: 500g/Month
Transport Package: by Glass Vials
Payment Terms: T/T, Western Union, Paypal, Money Gram, Bitcoin

Request a custom order and have something just for you!

Send Customized Request
Basic Info
  • Model NO.: Cjc-1295 No Dac (MOD GRF 1-29)
  • Customized: Customized
  • Suitable for: Lab Research
  • Purity: >98%
  • CAS No: 863288-34-0
  • Molecular Weight: 3367.2
  • Specification: 2mg/vial
  • HS Code: 3001901000
  • Powder: Yes
  • Certification: GMP, HSE, ISO 9001, USP, BP
  • State: Solid
  • Color: White
  • Molecular Formula: C152h252n44o42
  • Trademark: UP-BIO
  • Origin: China
Product Description
All the information below is strictly for research purposes only. Under no circumstance should this chemical be used for human consumption.

Cjc-1295 No-Dac (MOD GRF 1-29) (WITHOUT DAC)

CJC-1295 Chemical Profile
CAS: 863288-34-0
Formula: C152H252N44O42
Molecular weight: 3367.2
Peptide purity: > 98.0%
Chain:Tyr-d-ALA-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
 
CJC 1295 NO DAC

In the healthy human body, large amounts of growth hormone are stored in the pituitary. The cells within the pituitary release growth hormone in response to signaling by GHRH (Growth Hormone Releasing Hormone), Ghrelin (of which GHRPs - Growth Hormone Releasing Peptides - are mimetics), and are inhibited from releasing these stores by Somatostatin. GHRH and Ghrelin act on different populations of somatotropes (GH releasing cells). GHRP/Ghrelin increases the number of somatotropes releasing GH but not the amount released by each cell; GHRH affects both the number of secreting cells and - more so - the amount they each secrete. [1] GHRH and Ghrelin are released in specific patterns that vary depending on event and environment: post-exercise, in response to slow wave sleep, in certain stages of life and physical development, and so on.

Most people (even the diseased) continue to possess the ability to make GH in the pituitary. The problem is in the signaling of the pituitary to release it and make more. Even most people with diseases that affect growth hormone secretion retain the ability to continue to make GH in their pituitaries. The disease states and symptoms result, most typically, in altered (dysfunctional) GH release signaling and this also affects the ability of the pituitary to continue to make more GH. [2]

Endogenous-type GHRH, which has a forty-four amino acid long chain (and a specific shape - thus making it a peptide as well as a hormone), has been marketed for the longest as Sermorelin in comparison to the other GHRH-type peptides. However, Sermorelin has been demonstrated to be degraded rapidly in the body and is cost-inefficient. But because most patients in need of GH therapy do retain the ability to produce and secrete their own GH, treatment with a GHRH-type analog remained hypothetically preferable to exogenous GH treatment. GH itself when administered exogenously results not only in "unnatural" release patterns, it results universally in down regulation of endogenous GH production - as do many hormones when applied exogenously.[3]

Sermorelin's limitations naturally resulted in a variety of formulations of GHRH analogs for therapeutic usage. CJC-1295, discussed in another article, is a GHRH analogue with attached MPA (aka DAC), binds to albumin in the bloodstream and circulates for a week or longer. Modified GRF 1-29, which is also called D-Ala2-GHRH-(1-29), [Nle27]-hGHRH(1-29)-NH2, GHRH (1-29)NH2, or ModGRF1-29, is the bioactive portion of GHRH(1-44) with fifteen amino acids subtracted and four amino acids replaced at the weakest points in the peptide structure.

WARNING This product is a very potent chemical. This product is NOT for human use and can be harmful if ingested. This product is for research/laboratory use only. This product is NOT in a sterile solution and is NOT to be injected. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and should not be misbranded, misused or mislabeled as a drug, food or cosmetic.



Why choose us:
 
1. GMP lab to guarantee the quality.
 
2. Custom peptides, HPLC and MS are available.
 
3. Warehouses in USA, France and Australia to support your urgent need.
 
4. Doing drop shipping if needed.
 
5. Western Union/ Money Gram/ Bank Transfer/ Bitcoin/ Paypal for your option.
 
 
Hot-selling products:
               NameSpecification (10vial/box)
Melanotan I10mg/vial 
Melanotan II10mg/vial 
CJC 12952mg/vial 
CJC 1295 DAC2mg/vial 
Sermorelin2mg/vial, 5mg/vial 
PT 14110mg/vial 
Ipamorelin             2mg/vial, 5mg/vial 
MGF                     2mg/vial 
PEG MGF2mg/vial 
GHRP-65mg/vial 
GHRP-25mg/vial 
Hexarelin2mg/vial, 5mg/vial 
Thymosin Beta 4 (TB4) (TB-500)2mg/vial
Follistatin 3441mg/vial 
Oxytocin  2mg/vial 
Epitalon10mg/vial
DSIP2mg/vial, 5mg/vial 
Selank2mg/vial, 5mg/vial 
BPC 1575mg/vial 
Gonadorelin2mg/vial
Triptorelin  GNRH2mg/vial 
GHRH2mg/vial 
Tesamorelin2mg/vial 
ACE0311mg/vial
GDF-81mg/vial
Send your message to this supplier
Avatar
Miss Carla--WhatsApp--86-158 7005 0273
sales person
*From:
To: Miss Carla--WhatsApp--86-158 7005 0273
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

Find Similar Products By Category